Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Apportionment of damages and post-grant review of patents (S. 515; H.R. 1260)
Apportionment of damages and post-grant review of patents (S. 515; H.R. 1260)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MERCK & CO INC via MERCK & CO, INC.
2010 · first_quarter · 1A
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Source: Senate LDA
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Apportionment of damages and post-grant review of patents (S. 515; H.R. 1260)
Apportionment of damages and post-grant review of patents (S. 515; H.R. 1260)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Issues related to patent reform legislation (S. 515; HR 1260).
Issues related to patent reform legislation (S. 515; HR 1260).
Issues related to patent reform legislation (S. 515; HR 1260).
Issues related to patent reform legislation (S. 515; HR 1260).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; America's Healthy Futures Act of 2009). Oppose expansion of or increase in Medicaid rebate (HR 3200; American's Healthy Futures Act of 2009).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Issues related to patent reform legislation (S. 515; HR 1260).
Issues related to patent reform legislation (S. 515; HR 1260).
Issues related to patent reform legislation (S. 515; HR 1260).
Issues related to patent reform legislation (S. 515; HR 1260).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
To direct the Secretary of Veterans Affairs to establish a process for determining whether a geographic area is sufficiently served by the national cemeteries located in that geographic area.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 10 Budget and L-HHS Appropriations bill). Issues related to seasonal and pandemic influenza funding (H.R. 2346; FY10 Labor-HHS Appropriations bill)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Improvements for Patients and Providers Act of 2008
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Improvements for Patients and Providers Act of 2008
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
Apportionment of damages and post-grant review of patents (S. 515; H.R. 1260)
Increased funding for CDC's National Immunization Program (Sec. 317 program); increased funding for AIDS Drug Assistance Program (ADAP) (FY11 Budget, LHHS Appropriations bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MERCK & CO INC via MERCK & CO, INC.
2010 · first_quarter · Q1
Apportionment of damages and post-grant review of patents (S. 515; H.R. 1260)
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
Increased funding for CDC's National Immunization Program (Sec. 317 Program); increased funding for the AIDS Drug Assistance Program (FY 11 Budget and Labor-Health & Human Services Appropriations bill)
Approval and regulation of biosimilars (H.R. 1427; H.R. 1548; S. 726; H.R. 3200; S. 1679; H.R. 4872)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MERCK & CO INC via MERCK & CO, INC.
2009 · fourth_quarter · Q4
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
Issues related to patent reform legislation (S. 515; HR 1260).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 10 Budget and L-HHS Appropriations bill).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MERCK & CO INC via MERCK & CO, INC.
2009 · third_quarter · Q3
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 10 Budget and L-HHS Appropriations bill).
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726, HR 3200, S. 1679).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; America's Healthy Futures Act of 2009). Oppose expansion of or increase in Medicaid rebate (HR 3200; American's Healthy Futures Act of 2009).
Issues related to patent reform legislation (S. 515; HR 1260).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MERCK & CO INC via MERCK & CO, INC.
2009 · second_quarter · Q2
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Issues related to patent reform legislation (S. 515; HR 1260).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 10 Budget and L-HHS Appropriations bill). Issues related to seasonal and pandemic influenza funding (H.R. 2346; FY10 Labor-HHS Appropriations bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MERCK & CO INC via MERCK & CO, INC.
2009 · first_quarter · Q1
Issues related to approval and regulation of biosimilars (H.R. 1427, H.R. 1548, S. 726).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 10 Budget; FY '09 Omnibus; Economic Recovery Act).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
MERCK & CO INC via MERCK & CO, INC.
2008 · fourth_quarter · Q4
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029)
MERCK & CO INC via MERCK & CO, INC.
2008 · third_quarter · Q3
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
MERCK & CO INC via MERCK & CO, INC.
2008 · second_quarter · Q2
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
MERCK & CO INC via MERCK & CO, INC.
2008 · first_quarter · Q1
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
MERCK & CO INC via MERCK & CO, INC.
2007 · year_end · YY
Support amendments to patent reform legislation concerning post-grant review authority, apportionment of damages, venue and inequitable conduct provisions (S. 1145, H.R. 1908)
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Merdicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
MERCK & CO INC via MERCK & CO, INC.
2007 · mid_year · MM
Support amendments to Patent reform legislation concerning post-grant review authority, apportionment of damages and inequitable conduct provisions (S. 1145, H.R. 1908).
Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
MERCK & CO INC via MERCK & CO, INC.
2006 · year_end · YY
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2007 Labor-HHS Approprations bills)
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific bill) Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill)
MERCK & CO INC via MERCK & CO, INC.
2006 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO INC via MERCK & CO, INC.
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO INC via MERCK & CO, INC.
2004 · year_end · YY
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2003 · year_end · YY
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2003 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2002 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
MERCK & CO INC via MERCK & CO, INC.
2002 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
MERCK & CO INC via MERCK & CO, INC.
2001 · mid_year · MM
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of
MERCK & CO INC via MERCK & CO, INC.
2000 · year_end · YY
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2000 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
1999 · mid_year · MM
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Issues related to patent reform legislation (S. 515; HR 1260).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
Support amendments to patent reform legislation (S. 1145, H.R. 1908).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Educate members of Congress, USTR, Commerce, State on compulsory licenses in Thailand and Brazil (no specific legislation). Support intellectual property protections in trade negotiations. (Peru FTA, Panama FTA, Columbia FTA, Korea FTA).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2008 Labor-HHS Appropriations bills) Support increased funding for FDA (FY 2008 Agriculture Appropriations bills).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2008 Labor-HHS Appropriations bills) Support increased funding for FDA (FY 2008 Agriculture Appropriations bills).
Educate members of Congress, USTR, Commerce, State on compulsory licenses in Thailand and Brazil (no specific legislation). Support intellectual property protections in trade negotiations. (Peru FTS, Panama FTA, Coumbia FTA, Korea FTA).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Support efforts to add HPV vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund (H.R. 5495)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office